{"cik":1253689,"taxonomy":"us-gaap","tag":"IncreaseDecreaseInAccountsReceivable","label":"Increase (Decrease) in Accounts Receivable","description":"The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.","entityName":"Crescent Biopharma, Inc.","units":{"USD":[{"start":"2015-01-01","end":"2015-06-30","val":20000000,"accn":"0001193125-15-281118","fy":2015,"fp":"Q2","form":"10-Q","filed":"2015-08-06"},{"start":"2015-01-01","end":"2015-06-30","val":-20000000,"accn":"0001558370-16-007379","fy":2016,"fp":"Q2","form":"10-Q","filed":"2016-08-04"},{"start":"2024-09-20","end":"2024-12-31","val":0,"accn":"0001628280-26-011983","fy":2025,"fp":"FY","form":"10-K","filed":"2026-02-26","frame":"CY2024Q4"},{"start":"2025-01-01","end":"2025-03-31","val":0,"accn":"0001628280-26-028362","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-04-29","frame":"CY2025Q1"},{"start":"2025-01-01","end":"2025-12-31","val":18000000,"accn":"0001628280-26-011983","fy":2025,"fp":"FY","form":"10-K","filed":"2026-02-26","frame":"CY2025"},{"start":"2026-01-01","end":"2026-03-31","val":-18000000,"accn":"0001628280-26-028362","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-04-29","frame":"CY2026Q1"}]}}